Delivery Order SPE2DB20D1100-SPE2DB23FC4T4

Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $4.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $7,368.09 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 units of 0.05% RESTASIS eye emulsion. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is scheduled to be completed between July 27-28, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for eye medication supports the DLA's mission to provide logistics...
The Defense Logistics Agency awarded a $63,391 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued under an existing DLA-wide supply contract vehicle...
The Defense Logistics Agency awarded a $540,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply the emulsion, a prescription eye drop medication used to treat dry eyes. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 27-28, 2023. As a key logistics and procurement...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,173 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by September 15, 2023. As a major provider of medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,607 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is to provide 30 units of the product, with performance taking place in Conshohocken, Pennsylvania from July 17-18, 2023. As a major component of the Defense Department, the DLA supports America's armed forces by procuring nearly $20 billion worth of fuel, food, and healthcare supplies annually. Amerisourcebergen,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $630 to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The prime contractor will provide 30 units of the specified pharmaceutical product to be delivered to its Conshohocken, Pennsylvania facility by September 21, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in all...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $1,800.80 to Amerisourcebergen Drug Corporation for the supply of 30 units of 0.05% RESTASIS eye emulsion. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from August 22 to August 23, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a specific eye medication supports DLA's mission to provide logistics support for...
The Defense Logistics Agency awarded a $3,474.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561598309 RESTASIS 0.05% eye emulsion in 30 single-dose units. The single award was issued against an existing DLA pharmaceutical supply contract vehicle to provide the specified pharmaceutical product. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with delivery required between July 25-26, 2023. No set aside...
The Defense Logistics Agency awarded a $1,184 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The order is for 30 units of the product, which will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 22, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on the order, which was issued against an unspecified government-wide acquisition...
The Defense Logistics Agency awarded a $360,160 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. The firm fixed price order is for 30 units of the product and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 28, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This order for RESTASIS eye drops is...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC4T4
    Delivery Order

The Defense Logistics Agency awarded a $4,321 delivery order to Amerisourcebergen Drug Corporation for RESTASIS 0.05% eye emulsion. As the prime contractor, Amerisourcebergen will supply 60 units of the product to the DLA under a firm fixed price contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period from July 7-10, 2023. No subcontractors or set aside designations were identified. The DLA manages the global supply chain for the Department of Defense, procuring critical medical supplies and pharmaceuticals to support military treatment facilities and readiness worldwide.

Generated 12/22/23, 2:21 PM